Click here to submit an event to share with the GES Community.
This talk explores the fundamental question of what genome editing is and ought to mean.
IN-PERSON ONLY – NO ZOOM THIS WEEK. Request meeting with Paul Enriquez >
Despite the prominence and constant stream of genome-editing breakthroughs in recent years, there is surprisingly no unified or standard definition for the term genome editing. Scientific literature has devoted substantial ink to discussing how the technology was developed, its mechanisms of action, what it can be used for, how it can be improved to increase its efficient use, and so on without attempting to attach any specific or particular meaning to the term.
The increasingly interdisciplinary expansion of genome editing in a wide range of fields—spanning scientific, legal, economic, social, ethical, philosophical, and policy-related areas of study—guarantees that inconsistent meanings, interpretations, and uses of genome-editing definitions and terminology will obfuscate future discussions regarding what measures, if any, society should implement to promote or hinder technological development. Congruity and uniformity on genome-editing terminology is needed at this point to facilitate predictability in statutory and regulatory interpretation and avoid the institution of inadequate laws and policies. This presentation reflects on a fundamental question: What does it mean and, more importantly, what should it mean when people use the term genome editing?
GES Colloquium is jointly taught by Drs. Jen Baltzegar and Dawn Rodriguez-Ward, who you may contact with any class-specific questions. Colloquium will be held in-person in Poe 202, as well as live-streamed via Zoom. Please subscribe to the GES newsletter and Twitter for updates .